Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ultrasonic Therapy | 14 | 2011 | 215 | 2.230 |
Why?
|
Magnetic Resonance Imaging | 105 | 2022 | 36290 | 1.590 |
Why?
|
Prostatic Neoplasms | 56 | 2021 | 11345 | 1.540 |
Why?
|
Leiomyoma | 11 | 2007 | 654 | 1.330 |
Why?
|
Brachytherapy | 25 | 2013 | 1238 | 1.160 |
Why?
|
Prostate | 21 | 2022 | 1793 | 1.120 |
Why?
|
Uterine Neoplasms | 13 | 2007 | 1439 | 1.080 |
Why?
|
Image Interpretation, Computer-Assisted | 13 | 2019 | 3340 | 0.760 |
Why?
|
Magnetic Resonance Imaging, Interventional | 2 | 2015 | 187 | 0.700 |
Why?
|
Image Enhancement | 15 | 2016 | 2881 | 0.560 |
Why?
|
Pattern Recognition, Automated | 5 | 2016 | 994 | 0.560 |
Why?
|
Biopsy, Needle | 9 | 2007 | 1630 | 0.520 |
Why?
|
Subtraction Technique | 5 | 2004 | 510 | 0.500 |
Why?
|
Imaging, Three-Dimensional | 10 | 2013 | 4048 | 0.490 |
Why?
|
Radiology | 3 | 2020 | 2102 | 0.490 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2009 | 3765 | 0.430 |
Why?
|
Radiology, Interventional | 2 | 2015 | 475 | 0.420 |
Why?
|
Neurosurgery | 2 | 2016 | 670 | 0.370 |
Why?
|
Monitoring, Intraoperative | 4 | 2005 | 942 | 0.360 |
Why?
|
Prostatectomy | 10 | 2009 | 1956 | 0.350 |
Why?
|
Algorithms | 12 | 2016 | 13981 | 0.330 |
Why?
|
Prenatal Diagnosis | 5 | 2004 | 1264 | 0.320 |
Why?
|
Vaginal Neoplasms | 2 | 2006 | 104 | 0.310 |
Why?
|
Light Coagulation | 1 | 2007 | 71 | 0.300 |
Why?
|
Uterine Diseases | 3 | 1997 | 117 | 0.280 |
Why?
|
Prostate-Specific Antigen | 12 | 2007 | 2529 | 0.280 |
Why?
|
Ureteral Calculi | 3 | 2003 | 116 | 0.260 |
Why?
|
Ultrasonography, Interventional | 3 | 2011 | 1502 | 0.260 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2006 | 100 | 0.250 |
Why?
|
Bile Duct Diseases | 1 | 2006 | 97 | 0.250 |
Why?
|
Prostatic Hyperplasia | 5 | 2000 | 530 | 0.250 |
Why?
|
Body Water | 1 | 2006 | 341 | 0.240 |
Why?
|
Sensitivity and Specificity | 26 | 2016 | 14660 | 0.240 |
Why?
|
Urinary Retention | 2 | 2005 | 106 | 0.230 |
Why?
|
Urinary Bladder | 5 | 2006 | 1166 | 0.220 |
Why?
|
Surgery, Computer-Assisted | 4 | 2007 | 1008 | 0.220 |
Why?
|
Pancreatic Diseases | 1 | 2006 | 343 | 0.220 |
Why?
|
Expert Systems | 1 | 2003 | 79 | 0.220 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2019 | 2782 | 0.210 |
Why?
|
Menstrual Cycle | 1 | 2006 | 536 | 0.210 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2003 | 141 | 0.210 |
Why?
|
Diagnostic Imaging | 5 | 2007 | 3527 | 0.200 |
Why?
|
Male | 91 | 2023 | 359744 | 0.200 |
Why?
|
ROC Curve | 11 | 2003 | 3568 | 0.200 |
Why?
|
Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 2001 | 15 | 0.200 |
Why?
|
Humans | 134 | 2023 | 760621 | 0.200 |
Why?
|
Congenital Abnormalities | 2 | 2004 | 704 | 0.200 |
Why?
|
Image Processing, Computer-Assisted | 11 | 2022 | 8950 | 0.190 |
Why?
|
Computer Systems | 4 | 2006 | 470 | 0.190 |
Why?
|
Reproducibility of Results | 18 | 2022 | 20080 | 0.190 |
Why?
|
Software Validation | 1 | 2001 | 59 | 0.190 |
Why?
|
Cholangitis, Sclerosing | 1 | 2023 | 177 | 0.190 |
Why?
|
Genital Neoplasms, Female | 3 | 2016 | 533 | 0.180 |
Why?
|
Models, Statistical | 6 | 2016 | 5075 | 0.170 |
Why?
|
Diseases in Twins | 1 | 2001 | 447 | 0.170 |
Why?
|
History, 21st Century | 2 | 2016 | 1575 | 0.170 |
Why?
|
Neoplasm Staging | 19 | 2007 | 11152 | 0.160 |
Why?
|
Contrast Media | 11 | 2007 | 5305 | 0.160 |
Why?
|
Pentetic Acid | 2 | 1995 | 209 | 0.150 |
Why?
|
Artifacts | 5 | 2012 | 1898 | 0.150 |
Why?
|
History, 20th Century | 2 | 2016 | 2773 | 0.150 |
Why?
|
Ovarian Neoplasms | 4 | 2003 | 4878 | 0.150 |
Why?
|
Magnetic Resonance Angiography | 2 | 2001 | 1431 | 0.140 |
Why?
|
Computer Simulation | 9 | 2016 | 6218 | 0.140 |
Why?
|
Placental Insufficiency | 1 | 2017 | 50 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 6 | 2013 | 9276 | 0.140 |
Why?
|
Oxides | 4 | 2003 | 401 | 0.140 |
Why?
|
Endometrial Neoplasms | 1 | 2006 | 1357 | 0.140 |
Why?
|
Hungary | 1 | 2016 | 82 | 0.140 |
Why?
|
Phantoms, Imaging | 5 | 2022 | 2512 | 0.130 |
Why?
|
Statistics as Topic | 1 | 2003 | 2362 | 0.130 |
Why?
|
Ultrasonography, Prenatal | 1 | 2004 | 1745 | 0.130 |
Why?
|
Biopsy | 6 | 2013 | 6771 | 0.130 |
Why?
|
Abortion, Therapeutic | 1 | 1995 | 35 | 0.130 |
Why?
|
Placenta, Retained | 1 | 1995 | 22 | 0.130 |
Why?
|
Urinary Reservoirs, Continent | 1 | 1995 | 29 | 0.130 |
Why?
|
Rectum | 5 | 2006 | 895 | 0.120 |
Why?
|
Renal Veins | 2 | 1992 | 102 | 0.120 |
Why?
|
Oxygen | 2 | 2017 | 4193 | 0.120 |
Why?
|
Regression Analysis | 2 | 2001 | 6360 | 0.120 |
Why?
|
Organometallic Compounds | 2 | 1995 | 662 | 0.120 |
Why?
|
Robotics | 3 | 2007 | 874 | 0.120 |
Why?
|
Iodine Radioisotopes | 5 | 2000 | 1032 | 0.120 |
Why?
|
Middle Aged | 52 | 2023 | 220352 | 0.110 |
Why?
|
Predictive Value of Tests | 8 | 2020 | 15289 | 0.110 |
Why?
|
Uterus | 2 | 1997 | 651 | 0.110 |
Why?
|
Fetus | 1 | 2001 | 1859 | 0.110 |
Why?
|
Abdominal Neoplasms | 3 | 2003 | 286 | 0.110 |
Why?
|
Androgen Antagonists | 2 | 2003 | 1442 | 0.110 |
Why?
|
Radiotherapy Dosage | 6 | 2013 | 2897 | 0.110 |
Why?
|
Bayes Theorem | 1 | 2001 | 2326 | 0.110 |
Why?
|
Pelvic Neoplasms | 3 | 2003 | 248 | 0.110 |
Why?
|
Azasteroids | 1 | 1993 | 37 | 0.110 |
Why?
|
Aged | 41 | 2019 | 169152 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 18 | 2006 | 20509 | 0.110 |
Why?
|
Research | 1 | 2001 | 1974 | 0.100 |
Why?
|
Feasibility Studies | 4 | 2006 | 5201 | 0.100 |
Why?
|
Female | 54 | 2023 | 391270 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2001 | 1299 | 0.100 |
Why?
|
Placenta Accreta | 1 | 1995 | 237 | 0.100 |
Why?
|
Smoking Cessation | 1 | 2023 | 2064 | 0.100 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 1993 | 117 | 0.100 |
Why?
|
Panniculitis, Peritoneal | 1 | 1991 | 11 | 0.100 |
Why?
|
Androstenes | 1 | 1993 | 182 | 0.100 |
Why?
|
Principal Component Analysis | 2 | 2004 | 940 | 0.090 |
Why?
|
Patient Selection | 5 | 2006 | 4283 | 0.090 |
Why?
|
Mesentery | 1 | 1991 | 202 | 0.090 |
Why?
|
Iron | 4 | 2003 | 1786 | 0.090 |
Why?
|
Adult | 40 | 2023 | 219994 | 0.080 |
Why?
|
Pelvis | 2 | 2004 | 743 | 0.080 |
Why?
|
Brain Mapping | 1 | 2004 | 6568 | 0.080 |
Why?
|
Treatment Outcome | 16 | 2013 | 65017 | 0.080 |
Why?
|
Adenocarcinoma | 8 | 2005 | 6315 | 0.080 |
Why?
|
Magnetics | 1 | 2012 | 600 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2003 | 2557 | 0.080 |
Why?
|
Elasticity Imaging Techniques | 1 | 2013 | 388 | 0.080 |
Why?
|
Carcinoma, Transitional Cell | 1 | 1995 | 800 | 0.080 |
Why?
|
Models, Biological | 4 | 2006 | 9467 | 0.080 |
Why?
|
Gadolinium DTPA | 4 | 2004 | 823 | 0.070 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 3 | 2006 | 1660 | 0.070 |
Why?
|
Prospective Studies | 15 | 2013 | 54303 | 0.070 |
Why?
|
Infertility, Female | 2 | 2007 | 759 | 0.070 |
Why?
|
Leiomyomatosis | 1 | 2007 | 69 | 0.070 |
Why?
|
Phlebography | 2 | 2001 | 325 | 0.070 |
Why?
|
Radiation Injuries | 3 | 2003 | 1183 | 0.070 |
Why?
|
Urinary Bladder Neoplasms | 2 | 1998 | 2276 | 0.070 |
Why?
|
Postoperative Care | 2 | 2007 | 1479 | 0.070 |
Why?
|
Lymphatic Metastasis | 4 | 2003 | 2943 | 0.070 |
Why?
|
Colon, Sigmoid | 1 | 2006 | 124 | 0.060 |
Why?
|
Radiography | 3 | 2013 | 6965 | 0.060 |
Why?
|
Seminal Vesicles | 2 | 2004 | 107 | 0.060 |
Why?
|
Metabolic Clearance Rate | 1 | 2006 | 361 | 0.060 |
Why?
|
Intestinal Polyps | 1 | 1985 | 104 | 0.060 |
Why?
|
Normal Distribution | 2 | 2016 | 273 | 0.060 |
Why?
|
Premenopause | 2 | 2006 | 1038 | 0.060 |
Why?
|
Intraoperative Care | 3 | 2004 | 768 | 0.060 |
Why?
|
Therapy, Computer-Assisted | 1 | 2007 | 267 | 0.060 |
Why?
|
Ultrasonography | 8 | 2017 | 5961 | 0.060 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2007 | 861 | 0.060 |
Why?
|
Follow-Up Studies | 7 | 2013 | 39261 | 0.060 |
Why?
|
Pregnancy | 9 | 2017 | 29749 | 0.060 |
Why?
|
Radiometry | 2 | 2000 | 813 | 0.060 |
Why?
|
Needles | 1 | 2007 | 451 | 0.060 |
Why?
|
Thrombosis | 3 | 1995 | 3052 | 0.060 |
Why?
|
Carcinoma | 2 | 2007 | 2331 | 0.060 |
Why?
|
Equipment Design | 2 | 2003 | 3520 | 0.060 |
Why?
|
Lactates | 1 | 2004 | 404 | 0.060 |
Why?
|
Retrospective Studies | 11 | 2007 | 80372 | 0.060 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2007 | 304 | 0.060 |
Why?
|
Urethra | 2 | 2003 | 406 | 0.060 |
Why?
|
Observer Variation | 3 | 2000 | 2601 | 0.060 |
Why?
|
Pregnancy Trimester, Second | 2 | 2004 | 732 | 0.050 |
Why?
|
Boston | 1 | 2016 | 9280 | 0.050 |
Why?
|
Body Temperature | 1 | 2006 | 777 | 0.050 |
Why?
|
Metabolism, Inborn Errors | 1 | 2004 | 285 | 0.050 |
Why?
|
Self Medication | 1 | 2002 | 117 | 0.050 |
Why?
|
Taxoids | 1 | 2005 | 669 | 0.050 |
Why?
|
Niacin | 1 | 2002 | 119 | 0.050 |
Why?
|
Pregnancy Trimester, Third | 1 | 2004 | 582 | 0.050 |
Why?
|
Vagina | 2 | 2006 | 837 | 0.050 |
Why?
|
Ovary | 3 | 2001 | 958 | 0.050 |
Why?
|
Liver Neoplasms | 6 | 2000 | 4319 | 0.050 |
Why?
|
Vascular Diseases | 1 | 1990 | 1182 | 0.050 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2005 | 626 | 0.050 |
Why?
|
Body Temperature Regulation | 1 | 2003 | 286 | 0.050 |
Why?
|
Calibration | 2 | 2000 | 816 | 0.050 |
Why?
|
Ultrasonography, Doppler | 2 | 2000 | 465 | 0.050 |
Why?
|
Biophysical Phenomena | 1 | 2001 | 320 | 0.050 |
Why?
|
Salvage Therapy | 1 | 2007 | 1268 | 0.050 |
Why?
|
Twins, Conjoined | 1 | 2000 | 41 | 0.040 |
Why?
|
Preoperative Care | 3 | 2009 | 2256 | 0.040 |
Why?
|
Data Interpretation, Statistical | 2 | 2016 | 2696 | 0.040 |
Why?
|
Biophysics | 1 | 2001 | 380 | 0.040 |
Why?
|
Equipment Safety | 1 | 2001 | 253 | 0.040 |
Why?
|
Acidosis, Lactic | 1 | 2001 | 145 | 0.040 |
Why?
|
Precancerous Conditions | 1 | 2007 | 977 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2006 | 8056 | 0.040 |
Why?
|
Leiomyosarcoma | 1 | 2003 | 424 | 0.040 |
Why?
|
Pilot Projects | 2 | 2006 | 8555 | 0.040 |
Why?
|
Cerebral Ventricles | 1 | 2001 | 542 | 0.040 |
Why?
|
Urination Disorders | 1 | 2000 | 240 | 0.040 |
Why?
|
Fetofetal Transfusion | 1 | 2000 | 112 | 0.040 |
Why?
|
Fetal Heart | 1 | 2000 | 281 | 0.040 |
Why?
|
Cerebrospinal Fluid | 1 | 2001 | 544 | 0.040 |
Why?
|
Diagnosis, Differential | 7 | 2004 | 12965 | 0.040 |
Why?
|
Brain Neoplasms | 3 | 2004 | 8986 | 0.040 |
Why?
|
Neoplasms | 2 | 2023 | 22072 | 0.040 |
Why?
|
Brazil | 1 | 2022 | 1218 | 0.040 |
Why?
|
Drug Interactions | 1 | 2002 | 1428 | 0.040 |
Why?
|
Urogenital System | 1 | 1998 | 88 | 0.040 |
Why?
|
Female Urogenital Diseases | 1 | 1998 | 57 | 0.040 |
Why?
|
Brain | 3 | 2017 | 26951 | 0.040 |
Why?
|
Hysterosalpingography | 1 | 1997 | 26 | 0.040 |
Why?
|
Ferrosoferric Oxide | 4 | 2003 | 348 | 0.040 |
Why?
|
Reference Values | 1 | 2004 | 4925 | 0.040 |
Why?
|
Liver | 5 | 2017 | 7509 | 0.030 |
Why?
|
Aged, 80 and over | 6 | 2013 | 58995 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2001 | 1832 | 0.030 |
Why?
|
Quality of Life | 4 | 2023 | 13308 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2002 | 908 | 0.030 |
Why?
|
Magnetite Nanoparticles | 4 | 2003 | 316 | 0.030 |
Why?
|
Dextrans | 4 | 2003 | 574 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2003 | 2698 | 0.030 |
Why?
|
Lactic Acid | 1 | 2001 | 1134 | 0.030 |
Why?
|
Leg | 1 | 2001 | 1090 | 0.030 |
Why?
|
Fallopian Tubes | 1 | 1997 | 178 | 0.030 |
Why?
|
Neoplasm Invasiveness | 3 | 2004 | 3618 | 0.030 |
Why?
|
Fetal Diseases | 1 | 2001 | 911 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2003 | 1131 | 0.030 |
Why?
|
Monte Carlo Method | 1 | 2001 | 1257 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2042 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2004 | 6238 | 0.030 |
Why?
|
Priapism | 1 | 1995 | 29 | 0.030 |
Why?
|
Hyperoxia | 1 | 2017 | 250 | 0.030 |
Why?
|
Angiomyolipoma | 1 | 1996 | 184 | 0.030 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2003 | 1529 | 0.030 |
Why?
|
Penile Erection | 1 | 1995 | 100 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2007 | 3448 | 0.030 |
Why?
|
Urologic Diseases | 1 | 1997 | 248 | 0.030 |
Why?
|
Perfusion | 1 | 2019 | 1376 | 0.030 |
Why?
|
Pregnancy, Ectopic | 1 | 1995 | 143 | 0.030 |
Why?
|
Lymphatic Diseases | 1 | 1995 | 319 | 0.030 |
Why?
|
Colonic Neoplasms | 1 | 1985 | 2526 | 0.030 |
Why?
|
Forecasting | 2 | 2001 | 2932 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2000 | 1403 | 0.030 |
Why?
|
Neoplasms, Second Primary | 1 | 2001 | 1056 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1931 | 0.030 |
Why?
|
Vena Cava, Inferior | 1 | 1995 | 458 | 0.030 |
Why?
|
Organ Size | 1 | 2017 | 2254 | 0.020 |
Why?
|
Finasteride | 1 | 1993 | 90 | 0.020 |
Why?
|
Health Behavior | 1 | 2023 | 2622 | 0.020 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 1997 | 707 | 0.020 |
Why?
|
Cystadenoma | 1 | 1991 | 79 | 0.020 |
Why?
|
Genitalia, Female | 1 | 1992 | 147 | 0.020 |
Why?
|
Spleen | 2 | 1994 | 2298 | 0.020 |
Why?
|
Cryotherapy | 2 | 2003 | 161 | 0.020 |
Why?
|
Genital Diseases, Female | 1 | 1992 | 191 | 0.020 |
Why?
|
Palpation | 1 | 1991 | 166 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2003 | 3811 | 0.020 |
Why?
|
Sclerosis | 1 | 1991 | 210 | 0.020 |
Why?
|
Gadolinium | 1 | 1995 | 959 | 0.020 |
Why?
|
Portasystemic Shunt, Surgical | 1 | 1990 | 39 | 0.020 |
Why?
|
Lung Diseases, Fungal | 1 | 1991 | 126 | 0.020 |
Why?
|
Granulomatous Disease, Chronic | 1 | 1991 | 173 | 0.020 |
Why?
|
Thoracic Diseases | 1 | 1991 | 99 | 0.020 |
Why?
|
Cystectomy | 1 | 1995 | 697 | 0.020 |
Why?
|
Proteinuria | 1 | 1992 | 594 | 0.020 |
Why?
|
Biliary Tract Neoplasms | 1 | 1991 | 184 | 0.020 |
Why?
|
Vascular Patency | 1 | 1992 | 901 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2007 | 15840 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 1998 | 3529 | 0.020 |
Why?
|
Embolism | 1 | 1992 | 408 | 0.020 |
Why?
|
Sialography | 1 | 1988 | 6 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2016 | 1489 | 0.020 |
Why?
|
Aspergillosis | 1 | 1991 | 243 | 0.020 |
Why?
|
Computational Biology | 1 | 2001 | 3505 | 0.020 |
Why?
|
Parotid Diseases | 1 | 1988 | 49 | 0.020 |
Why?
|
Motion | 1 | 2012 | 779 | 0.020 |
Why?
|
Erectile Dysfunction | 1 | 1991 | 452 | 0.020 |
Why?
|
Male Urogenital Diseases | 1 | 2007 | 48 | 0.020 |
Why?
|
Abdomen | 1 | 1993 | 1130 | 0.020 |
Why?
|
Probability | 1 | 1992 | 2475 | 0.020 |
Why?
|
Learning | 1 | 1996 | 1739 | 0.020 |
Why?
|
Kidney Neoplasms | 2 | 1996 | 4312 | 0.020 |
Why?
|
Aortic Aneurysm | 1 | 1991 | 648 | 0.020 |
Why?
|
Pain | 2 | 2003 | 5066 | 0.020 |
Why?
|
Smoking | 1 | 2023 | 9073 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2004 | 26181 | 0.020 |
Why?
|
Anemia, Sickle Cell | 1 | 1995 | 1056 | 0.020 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2006 | 119 | 0.020 |
Why?
|
Software | 1 | 2000 | 4419 | 0.020 |
Why?
|
Neuronavigation | 1 | 2007 | 164 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2001 | 5761 | 0.020 |
Why?
|
Postoperative Period | 1 | 1990 | 1818 | 0.020 |
Why?
|
Utah | 1 | 2004 | 131 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 1992 | 1273 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2003 | 1791 | 0.020 |
Why?
|
Laser Therapy | 2 | 2003 | 1089 | 0.020 |
Why?
|
Time Factors | 4 | 2007 | 40165 | 0.010 |
Why?
|
Perimenopause | 1 | 2006 | 141 | 0.010 |
Why?
|
Retroperitoneal Neoplasms | 1 | 1988 | 329 | 0.010 |
Why?
|
Lymphoma | 1 | 1993 | 1898 | 0.010 |
Why?
|
Finite Element Analysis | 1 | 2006 | 428 | 0.010 |
Why?
|
Life Tables | 1 | 2003 | 365 | 0.010 |
Why?
|
Neoadjuvant Therapy | 2 | 2005 | 2821 | 0.010 |
Why?
|
Receptors, LHRH | 1 | 2003 | 158 | 0.010 |
Why?
|
Precipitating Factors | 1 | 2002 | 51 | 0.010 |
Why?
|
Ejaculation | 1 | 2002 | 59 | 0.010 |
Why?
|
Elasticity | 1 | 2004 | 652 | 0.010 |
Why?
|
Fetal Death | 1 | 2004 | 434 | 0.010 |
Why?
|
Proctitis | 1 | 2002 | 41 | 0.010 |
Why?
|
Breast | 1 | 1992 | 1963 | 0.010 |
Why?
|
Myocardium | 1 | 1995 | 4700 | 0.010 |
Why?
|
Prothrombin Time | 1 | 2002 | 116 | 0.010 |
Why?
|
Decision Making | 1 | 1996 | 3925 | 0.010 |
Why?
|
Fertility | 1 | 2007 | 773 | 0.010 |
Why?
|
Evaluation Studies as Topic | 2 | 1995 | 1628 | 0.010 |
Why?
|
Mammaplasty | 1 | 1992 | 1240 | 0.010 |
Why?
|
Retroperitoneal Space | 2 | 1995 | 173 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 1995 | 2942 | 0.010 |
Why?
|
Radiotherapy, Conformal | 1 | 2004 | 549 | 0.010 |
Why?
|
Radiation Dosage | 2 | 2000 | 1958 | 0.010 |
Why?
|
Immobilization | 1 | 2001 | 230 | 0.010 |
Why?
|
Fetal Growth Retardation | 1 | 2004 | 579 | 0.010 |
Why?
|
Clinical Competence | 1 | 1996 | 4783 | 0.010 |
Why?
|
Chronic Disease | 2 | 1992 | 9287 | 0.010 |
Why?
|
Quality Control | 1 | 2003 | 828 | 0.010 |
Why?
|
Posture | 1 | 2004 | 953 | 0.010 |
Why?
|
Adolescent | 8 | 2003 | 87810 | 0.010 |
Why?
|
Risk Assessment | 3 | 2007 | 24123 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 1998 | 5351 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8803 | 0.010 |
Why?
|
Lymph Nodes | 2 | 2003 | 3486 | 0.010 |
Why?
|
Radiotherapy, Computer-Assisted | 1 | 2000 | 90 | 0.010 |
Why?
|
Hemorrhage | 1 | 1991 | 3600 | 0.010 |
Why?
|
Peritoneum | 1 | 2000 | 224 | 0.010 |
Why?
|
False Positive Reactions | 2 | 1992 | 956 | 0.010 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2000 | 354 | 0.010 |
Why?
|
Acute Disease | 2 | 2005 | 7269 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 2007 | 1190 | 0.010 |
Why?
|
Analgesia | 1 | 2003 | 459 | 0.010 |
Why?
|
Safety | 1 | 2003 | 1148 | 0.010 |
Why?
|
Survival Rate | 1 | 2013 | 12808 | 0.010 |
Why?
|
Perineum | 1 | 2000 | 208 | 0.010 |
Why?
|
Biomedical Engineering | 1 | 2000 | 289 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2003 | 1722 | 0.010 |
Why?
|
Drainage | 1 | 2003 | 1161 | 0.010 |
Why?
|
Movement | 1 | 2004 | 1474 | 0.010 |
Why?
|
Androgens | 1 | 2005 | 1291 | 0.010 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 1988 | 1403 | 0.010 |
Why?
|
Hysterectomy | 1 | 2003 | 904 | 0.010 |
Why?
|
United States | 2 | 2009 | 72461 | 0.010 |
Why?
|
Antibiotic Prophylaxis | 1 | 2002 | 643 | 0.010 |
Why?
|
Case-Control Studies | 1 | 1995 | 22053 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2005 | 4899 | 0.010 |
Why?
|
Benzodiazepines | 1 | 2003 | 1131 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2007 | 6544 | 0.010 |
Why?
|
Heart | 2 | 2003 | 4393 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 1996 | 6853 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2004 | 12159 | 0.010 |
Why?
|
Linear Models | 1 | 2006 | 5877 | 0.010 |
Why?
|
Hyperthermia, Induced | 1 | 2000 | 417 | 0.010 |
Why?
|
Hematuria | 1 | 1997 | 233 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15687 | 0.010 |
Why?
|
Gestational Age | 1 | 2004 | 3565 | 0.010 |
Why?
|
Vascular Surgical Procedures | 1 | 2003 | 1475 | 0.010 |
Why?
|
Carcinoma, Renal Cell | 1 | 1990 | 3218 | 0.010 |
Why?
|
Collateral Circulation | 1 | 1995 | 292 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23376 | 0.010 |
Why?
|
Penis | 1 | 1995 | 212 | 0.010 |
Why?
|
Kidney Cortex | 1 | 1993 | 169 | 0.010 |
Why?
|
Hepatic Veins | 1 | 1993 | 112 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 2282 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2003 | 6828 | 0.010 |
Why?
|
Dogs | 1 | 1998 | 3841 | 0.010 |
Why?
|
Cryosurgery | 1 | 1998 | 475 | 0.010 |
Why?
|
Abdominal Muscles | 1 | 1993 | 170 | 0.010 |
Why?
|
Bile Ducts | 1 | 1993 | 282 | 0.010 |
Why?
|
Specialization | 1 | 1997 | 778 | 0.010 |
Why?
|
Portal Vein | 1 | 1993 | 429 | 0.010 |
Why?
|
Radiographic Image Enhancement | 1 | 1995 | 875 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1995 | 2234 | 0.010 |
Why?
|
Child | 3 | 1995 | 79806 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2005 | 12766 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2003 | 2758 | 0.010 |
Why?
|
Hypertrophy | 1 | 1992 | 555 | 0.010 |
Why?
|
Equipment Failure | 1 | 1992 | 577 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1995 | 3465 | 0.010 |
Why?
|
Melanoma | 1 | 1988 | 5697 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2003 | 12531 | 0.010 |
Why?
|
Research Design | 1 | 2004 | 6180 | 0.000 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 1991 | 506 | 0.000 |
Why?
|
Medicine | 1 | 1997 | 943 | 0.000 |
Why?
|
Colon | 1 | 1996 | 1788 | 0.000 |
Why?
|
Polysomnography | 1 | 1995 | 1825 | 0.000 |
Why?
|
Endoscopy | 1 | 1998 | 1838 | 0.000 |
Why?
|
Pancreas | 1 | 1993 | 1677 | 0.000 |
Why?
|
Angiography | 1 | 1991 | 1605 | 0.000 |
Why?
|
Pregnancy Outcome | 1 | 1995 | 2907 | 0.000 |
Why?
|
Aorta | 1 | 1991 | 2039 | 0.000 |
Why?
|
Heart Defects, Congenital | 1 | 2000 | 4673 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2006 | 15697 | 0.000 |
Why?
|
Logistic Models | 1 | 1997 | 13314 | 0.000 |
Why?
|
Electrocardiography | 1 | 1995 | 6414 | 0.000 |
Why?
|
Adipose Tissue | 1 | 1993 | 3301 | 0.000 |
Why?
|
Child, Preschool | 2 | 1995 | 42063 | 0.000 |
Why?
|
Age Factors | 1 | 1997 | 18416 | 0.000 |
Why?
|
Risk Factors | 1 | 2007 | 74359 | 0.000 |
Why?
|
Prognosis | 1 | 1996 | 29658 | 0.000 |
Why?
|
Infant | 1 | 1995 | 36060 | 0.000 |
Why?
|
Animals | 1 | 1998 | 167963 | 0.000 |
Why?
|